Form 4: TransMedics Group Director Exercises Options and Sells Shares
SEC Form 4 Filing
Director Edward M. Basile exercised stock options and sold shares of TransMedics Group, Inc. on May 9, 2025.
Summary
- On May 9, 2025, Edward M. Basile, a director of TransMedics Group, Inc., exercised stock options to acquire 6,000 shares of common stock at a price of $0.7 per share.
- Simultaneously, Basile sold 6,000 shares of common stock at a price of $115.63 per share.
- Following these transactions, Basile directly owns 732 shares of TransMedics Group, Inc. common stock.
- Basile also holds 13,285 derivative securities in the form of stock options.
Sentiment
Score: 5
Explanation: Neutral sentiment as it reports factual transactions without expressing any positive or negative outlook.
Industry Context
This Form 4 filing is a routine disclosure of insider transactions, providing transparency to investors regarding the actions of company directors.
Stakeholder Impact
- The transaction provides transparency to shareholders regarding insider activity.
Key Dates
| Date | Description |
|---|---|
| 2025-01-17 | Date of Power of Attorney execution. |
| 2025-02-16 | Date stock options become exercisable. |
| 2025-05-09 | Date of transaction: exercise of stock options and sale of shares. |
| 2025-05-13 | Date of signature for the report. |
| 2026-02-16 | Expiration date of stock options. |
Keywords
Form 4, TransMedics Group, TMDX, insider trading, stock options, share sale, Edward M. Basile, director
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.